| scholarly article | Q13442814 |
| P2093 | author name string | Jian Rong Sheng | |
| Matthew N Meriggioli | |||
| Michael H B Stowell | |||
| Palash Bhattacharya | |||
| Michael Artinger | |||
| Bellur S Prabahakar | |||
| Steve Grimme | |||
| P2860 | cites work | Main Immunogenic Region Structure Promotes Binding of Conformation-Dependent Myasthenia Gravis Autoantibodies, Nicotinic Acetylcholine Receptor Conformation Maturation, and Agonist Sensitivity | Q27658065 |
| Assembly of the nicotinic acetylcholine receptor. The first transmembrane domains of truncated alpha and delta subunits are required for heterodimer formation in vivo | Q28296161 | ||
| Refined structure of the nicotinic acetylcholine receptor at 4A resolution | Q28306592 | ||
| Myasthenia gravis | Q29396951 | ||
| Phylogenetic conservation of disulfide-linked, dimeric acetylcholine receptor pentamers in southern ocean electric rays. | Q30840215 | ||
| Nanodisc-incorporated hemagglutinin provides protective immunity against influenza virus infection | Q33558691 | ||
| Acetylcholine receptors and myasthenia | Q33862589 | ||
| Modes of action of Freund's adjuvants in experimental models of autoimmune diseases | Q34460923 | ||
| Applications of phospholipid bilayer nanodiscs in the study of membranes and membrane proteins. | Q34607664 | ||
| Transducin activation by nanoscale lipid bilayers containing one and two rhodopsins | Q34613826 | ||
| Nanodiscs separate chemoreceptor oligomeric states and reveal their signaling properties | Q34984384 | ||
| Circulating regulatory anti-T cell receptor antibodies in patients with myasthenia gravis | Q35140380 | ||
| Experimental autoimmune myasthenia gravis in the mouse | Q35644910 | ||
| Experimental myasthenia gravis. A murine system | Q36343285 | ||
| Immunology of disorders of neuromuscular transmission | Q36459475 | ||
| Self‐assembly of single integral membrane proteins into soluble nanoscale phospholipid bilayers | Q36631413 | ||
| Regulatory T cells induced by GM-CSF suppress ongoing experimental myasthenia gravis | Q36876703 | ||
| Nanotoxicity: the growing need for in vivo study | Q37045340 | ||
| Autoimmune myasthenia gravis: emerging clinical and biological heterogeneity | Q37315963 | ||
| The nanodisc: a novel tool for membrane protein studies | Q37488263 | ||
| Histological assessment of intermediate- and long-term creatine monohydrate supplementation in mice and rats | Q39125775 | ||
| Ultrastructural Localization of Immune Complexes (IGG and C3) at the End-Plate in Experimental Autoimmune Myasthenia Gravis | Q39847593 | ||
| Functional reconstitution of Beta2-adrenergic receptors utilizing self-assembling Nanodisc technology | Q40278356 | ||
| Myasthenia gravis as a prototype autoimmune receptor disease | Q41687580 | ||
| Immune complexes (IgG and C3) at the motor end-plate in myasthenia gravis: ultrastructural and light microscopic localization and electrophysiologic correlations | Q43866400 | ||
| Directed self-assembly of monodisperse phospholipid bilayer Nanodiscs with controlled size | Q44802076 | ||
| Specific immunoadsorption of the autoantibodies from myasthenic patients using the extracellular domain of the human muscle acetylcholine receptor alpha-subunit. Development of an antigen-specific therapeutic strategy | Q45225575 | ||
| Plasmapheresis in myasthenia gravis | Q46202751 | ||
| Preparation of an immunoadsorbent coupled with a recombinant antigen to remove anti-acetylcholine receptor antibodies in abnormal serum | Q46615548 | ||
| Using Nanodiscs to create water-soluble transmembrane chemoreceptors inserted in lipid bilayers | Q54438668 | ||
| Clinical trial of plasma exchange and high-dose intravenous immunoglobulin in myasthenia gravis | Q58416378 | ||
| Plasmapheresis and immunosuppressive drug therapy in myasthenia gravis | Q67700665 | ||
| Induction of Peripheral Tolerance with Peptide-Specific Anergy in Experimental Autoimmune Neuritis | Q72094652 | ||
| Treatment of myasthenia gravis by immunoadsorption of plasma | Q72541856 | ||
| Intravenous administration of deaggregated mouse thyroglobulin suppresses induction of experimental autoimmune thyroiditis and expression of both Th1 and Th2 cytokines | Q73419196 | ||
| The six year experience of plasmapheresis in patients with myasthenia gravis | Q74278304 | ||
| Suppression of experimental autoimmune myasthenia gravis by granulocyte-macrophage colony-stimulating factor is associated with an expansion of FoxP3+ regulatory T cells | Q79174410 | ||
| Immunoadsorption therapy and complement activation | Q81827135 | ||
| Assembly of single bacteriorhodopsin trimers in bilayer nanodiscs | Q83167921 | ||
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | myasthenia gravis | Q8285 |
| autoantibody | Q785022 | ||
| P304 | page(s) | 320-327 | |
| P577 | publication date | 2010-07-15 | |
| P1433 | published in | Experimental Neurology | Q5421127 |
| P1476 | title | In vivo adsorption of autoantibodies in myasthenia gravis using Nanodisc-incorporated acetylcholine receptor | |
| P478 | volume | 225 |
| Q35991625 | Engineered nanoparticles mimicking cell membranes for toxin neutralization |
| Q30840703 | Lipid-protein nanodiscs offer new perspectives for structural and functional studies of water-soluble membrane-active peptides |
| Q39126044 | Nanodiscs in Membrane Biochemistry and Biophysics. |
| Q28546012 | PET/CT Based In Vivo Evaluation of 64Cu Labelled Nanodiscs in Tumor Bearing Mice |
| Q39350771 | Recent advances in nanodisc technology for membrane protein studies (2012-2017). |
Search more.